TCW Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-84,794
| Closed | -$2.68M | – | 380 |
|
|
2023
Q3 | $2.68M | Buy |
84,794
+31,034
| +58% | +$981K | 0.03% | 205 |
|
|
2023
Q2 | $2.19M | Buy |
53,760
+1,209
| +2% | +$49.3K | 0.02% | 230 |
|
|
2023
Q1 | $1.96M | Buy |
52,551
+32,072
| +157% | +$1.2M | 0.03% | 219 |
|
|
2022
Q4 | $715K | Buy |
+20,479
| New | +$715K | 0.01% | 271 |
|